简体
简体中文
繁體中文

Bluejay Diagnostics, Inc. BJDX

等待开盘 03-27 09:30:00 美东时间

1.98

+0.040

+2.06%

华盛通华盛通
立即下载
  • 最 高2.11
  • 今 开1.925
  • 成交量 2.80万股
  • 最 低 1.70
  • 昨 收 1.94
  • 总市值 3.99万
  • 52周最高 10.20
  • 市盈率 --
  • 换手率 138.86%
  • 52周最低 0.6273
  • 委 比 -68.42%
  • 总股本 2.02万
  • 历史最高 13.9799
  • 量 比 1.70
  • 振 幅 21.13%
  • 历史最低 0.0652
  • 每 手 1
  • 风险率

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split, Effective Jan. 29

    Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today

    01-27 21:04

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

    Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...

    2025-12-29 20:05

  • Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

    Bluejay Diagnostics provides a mid-year update, highlighting advancements in its SYMON-II clinical trial for its Symphony IL-6 test, aiming to predict sepsis mortality. The company plans a 510(k) FDA submission by Q4 2027 and approval by Q3 2028. It is also working on manufacturing improvements and seeking $30 million in financing. The company has reduced its workforce to conserve cash and announced its 2025 Annual Meeting for stockholder approvals.

    2025-06-03 20:05

  • Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

    Shares of Zhibao Technology Inc. (NASDAQ:ZBAO) rose sharply in today's pre-market trading after the company announced that it has won a tender to provide high-end medical third party administration services to the People’s Insurance Company of China Limited. Zhibao Technology shares jumped 18.8% to ...

    2024-09-03 17:13

  • 12 Health Care Stocks Moving In Monday's After-Market Session

    Gainers Conduit Pharmaceuticals (NASDAQ:CDT) stock increased by 27.4% to $0.16 during Monday's after-market session. The company's market cap stands at $15.0 million. TNF Pharmaceuticals (NASDAQ:TNFA) stock moved upwards by 18.82% to $2.02. The market value of their outstanding shares is at $4.7 mil...

    2024-09-03 04:31